Objective To test the hypothesis that echocardiographic markers of pulmonary vascular disease (PVD) exist in asymptomatic infants born preterm at 1-year corrected age.
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Objective To test the hypothesis that echocardiographic markers of pulmonary vascular disease (PVD) exist in asymptomatic infants born preterm at 1-year corrected age.
Study design
We conducted a prospective cohort study of 80 infants born preterm (<29 weeks of gestation) and 100 age-and weight-matched infants born at term and compared broad-based conventional and quantitative echocardiographic measures of pulmonary hemodynamics at 1-year corrected age. Pulmonary artery acceleration time (PAAT), a validated index of pulmonary vascular resistance, arterial pressure, and compliance, was used to assess pulmonary hemodynamics. Lower PAAT is indicative of PVD. Subanalyses were performed in infants with bronchopulmonary dysplasia (BPD, n = 48, 59%) and/or late-onset pulmonary hypertension (n = 12, 15%).
Results At 1 year, there were no differences between conventional measures of pulmonary hypertension in the infants born at term and preterm. All infants born preterm had significantly lower values of PAAT than infants born at term (73 ± 8 milliseconds vs 98 ± 5 milliseconds, P < .001). Infants born preterm with BPD had even lower PAAT than those without BPD (69 ± 5 milliseconds vs 79 ± 4 milliseconds, P < .01). The degree of PVD at 1-year corrected age was inversely related to gestation in all infants born preterm. Data analysis included adjustment for ventricular function and other confounding factors.
Conclusions
In comparison with infants born at term, infants born preterm exhibit abnormal PAAT at 1-year corrected age irrespective of neonatal lung disease status, suggesting the existence of PVD beyond infancy. PAAT measurements offer a reliable, noninvasive tool for screening and longitudinal monitoring of pulmonary hemodynamics in infants. (J Pediatr 2018; 197:48-56 ). P ulmonary vascular disease (PVD) and its most severe form, pulmonary hypertension (PH), are common associations of neonatal respiratory diseases of prematurity, including bronchopulmonary dysplasia (BPD). 1 Although the reported incidence of PH is 14%-44% in infants with established BPD, depending on the definition of each disease, [2] [3] [4] [5] [6] recent evidence indicates that up to 20% of neonates of extremely low gestational age without BPD will develop some degree of PVD during the neonatal period. [3] [4] [5] [6] Although BPD and PH share similar risk factors and overlapping symptoms, 7 PVD may be a distinct entity in infants born premature. [3] [4] [5] [6] [7] [8] [9] [10] The diagnosis of PVD and the true prevalence of PH in infants born preterm have been difficult to discern because of a paucity of reliable noninvasive measures to evaluate pulmonary hemodynamics 1, 11, 12 and inconsistent screening for PVD and PH in neonates of extremely low gestational age. 13 The use of different clinical and echocardiographic screening algorithms for the detection of PH in infants born premature has been proposed but primarily focuses on infants with BPD. 11, 13 The noninvasive echocardiographic assessment of pulmonary hemodynamics in children relies on a combination of qualitative evaluations (ventricular septal wall position and right ventricle [RV] morphologic changes) and quantitative estimates based on the Doppler velocity of tricuspid regurgitation (DVTR), measures that often imprecisely correlate with cardiac catheterization indices.
14 Although right heart catheterization remains the gold standard for the assessment of pulmonary hemodynamics, its invasive nature and risk of radiation exposure limits its use as a screening and monitoring tool in this population. 15 Recent studies have established Doppler-derived pulmonary artery acceleration time (PAAT) as a comprehensive quantitative index of pulmonary artery pressure (PAP), vascular resistance, and compliance against simultaneous heart catheterization-derived pulmonary hemodynamic in children. 15 PAAT assesses the blood flow velocity characteristics in the right ventricular outflow tract (RVOT) in response to changes in RV mechanical performance and pulmonary vascular load and has superior diagnostic sensitivity for assessing PVD and following progression. 15, 16 Normative values and maturational patterns of PAAT recently have been established in healthy children. 16 We hypothesize that developmental and maturational disruption to the pulmonary vasculature from preterm birth results in PVD as a distinct pathophysiology from BPD that exists at 1-year corrected age. Our aim was to prospectively identify PVD using Doppler echocardiography-derived PAAT in a cohort of infants born preterm (with and without BPD) and compare it with healthy infants born at term at 1 year of age.
Methods
In a prospective observational study, we recruited a cohort of infants born preterm at birth and longitudinally followed them to 1-year corrected age. The infants were enrolled through the Prematurity and Respiratory Outcomes Program at Washington University School of Medicine/Saint Louis Children's Hospital neonatal intensive care unit between August 2011 and November 2013. The detailed design of the Prematurity and Respiratory Outcomes Program Study (ClinicalTrials.gov: NCT01435187) has been described. 17, 18 Reports on reference values and maturational patterns of ventricular function, namely RV fractional area of change (FAC) and left ventricle (LV) and RV strain, from these cohorts have been published recently, 4, 19 but PAAT and pulmonary hemodynamic data have not been reported.
Subjects were eligible for inclusion if they were born between 23 0/7 weeks and 28 6/7 weeks of gestational age and available for follow-up at 1-year corrected age. Subjects were excluded if they had any suspected congenital anomalies of the airways, congenital heart disease, intrauterine growth restriction, or were small for gestational age (birth weight <10th percentile for gestation). A cohort of healthy, age-and sex-matched infants born at term were recruited for the control group. These infants were referred to the Washington University Outpatient Pediatric Cardiology Clinic at Saint Louis Children's Hospital from August 2011 to November 2013 for heart murmur evaluation and found to have normal cardiac structure and function (Figure 1) . All subjects underwent a comprehensive clinical evaluation as part of the standard of care. The perinatal clinical information and demographic characteristics of the infants born preterm were obtained. The institutional review board for human studies at Washington University approved the study. Written informed consents were obtained from the parents/ guardians of the study subjects.
Echocardiography was performed via commercially available ultrasound imaging systems (Vivid 7 and 9; GE Medical Systems, Milwaukee, Wisconsin) by 1 designated certified pediatric cardiac sonographer using a phased-array transducer . The echocardiographic images were acquired via the use of a standardized image acquisition protocol based on the guidelines of the American Society of Echocardiography. 20 The image data were acquired digitally at 36 weeks of postmenstrual age (PMA) and 1-year corrected age in infants born preterm and at 1 year of age in infants born at term and stored in raw Digital Imaging and Communications in Medicine cine-loop format for offline analysis. Vital signs, including heart rate and blood pressure readings, were recorded at the time of each echocardiogram.
We assessed conventional echocardiographic measures of pulmonary hemodynamics, including the estimated RV systolic pressure, using the DVTR, the ratio of RV systolic pressure to systemic blood pressure, cardiac shunts and their directional flow, septal wall motion and position, and RV and right atrial morphology. We measured PAAT using a published protocol for PAAT image acquisition and postprocessing data analysis. 15 A spectral Doppler image was obtained by placing a pulsed Doppler sample volume at the pulmonary valve annulus in the parasternal short-axis view (Figure 2 ; available at www.jpeds.com). Maximal alignment of Doppler interrogation with blood flow direction was achieved with the placement of the sample volume at the annulus of the pulmonary valve and not more proximally in the RVOT. We calculated PAAT as the time interval between the onset of systolic pulmonary arterial flow (onset of ejection) and peak flow velocity. To account for the potential impact of heart rate variability, PAAT was adjusted for right ventricular ejection time (RVET) with a ratio of PAAT:RVET (Figure 2) . 15 As we and others have previously demonstrated no correlation between PAAT or PAAT:RVET and R-R interval in neonates, 15, 21 both PAAT and the ratio of PAAT:RVET were not corrected for R-R interval or its square root value in the analysis.
Because a lower PAAT reflects the triad of elevated PVR, decreased pulmonary arterial compliance, and RV mechanical performance, 15 we assessed measures of RV function and morphology. We evaluated RV function using speckle-tracking echocardiography-derived free wall longitudinal systolic strain (FWLS) and FAC by methods previously reported. 4, 19 We measured RV areas in systole and diastole, 19 RV 2-dimensional chamber dimensions at the basal and mid ventricular levels, and RV length from the apex to the base. 20 To test whether acceleration time across the RVOT is dependent on its diameter, 22 we measured the proximal and distal RVOT diameters. 20 We also examined LV function with speckle-tracking echocardiography-derived LV FWLS to assess the interventricular dependence.
We assessed for the contributions of BPD (using a modified definition of the 2001 National Institutes of Health BPD workshop 18 ) and late-onset PH (using a broad echocardiogrambased definition described by Mourani et al 3 ) on PAAT measures at 1-year corrected age. Infants born preterm were classified with late-onset PH at 36 weeks of PMA if they had 2 or more of the conventional echocardiographic measures of pulmonary hemodynamics listed previously. We used an established pediatric cut-off value of PAAT <90 milliseconds and 15 The independent effect of the risk factors for BPD and PH, including gestational age, sex, total oxygen days, length of hospital stay, perinatal factors, common neonatal morbidities (necrotizing enterocolitis, intraventricular hemorrhage, and retinopathy of prematurity), and presence of a patent ductus arteriosus (PDA) at 36 weeks of PMA 23 on PAAT also were accounted for in the analysis.
Intra-and interobserver variability for PAAT and PAAT:RVET were measured in 50% of the infants in each cohort by observers who were blinded to the clinical and demographic data. Each observer used the same measurement protocol 15 and was blinded to the other's results. Bland-Altman plot analysis (percentage bias, 95% limits of agreements [LOA]), coefficient of variation (CV), and intraclass correlation coefficient were used to assess the reproducibility.
Statistical Analyses
All demographic data are expressed as median with IQR or as percentages, and all echocardiographic data are expressed as mean ± SD. Continuous variables of PAAT were tested for normality via the Kolmogorov-Smirnov test and a histogram illustration of the data. ANOVA tests were used to compare the changes in PAAT values among infants born preterm with and without BPD and/or PH with infants born at term. Student t tests were used separately to compare the patterns between infants born preterm without complications and those with BPD and/or PH. All outcome variables with non-normal distributions were analyzed in simple comparisons via the Wilcoxon rank sum tests or Kruskal-Wallis 1-way ANOVA for tests with more than 2 independent groups. The c 2 test (or Fisher exact test as appropriate) was used to assess the association between categorical variables. Univariate analysis was used to determine the best predictors to enter in the model and then backward stepwise regression was performed to assess the independent effect of gestational age, sex, total oxygen days, length of stay, and common neonatal morbidities (necrotizing enterocolitis, intraventricular hemorrhage, and retinopathy of prematurity), while adjusting for weight and body surface area at examination. We performed stepwise regression to analyze the influence of PH and BPD on PAAT patterns at 1-year corrected age. 1, 3 The statistical analysis was performed with SPSS, version 14.0 (SPSS, Inc, Chicago, Illinois).
Results
A total of 180 infants (80 born at preterm and 100 born at term) were included in this study (Figure 1 ). Of the 137 infants born preterm recruited at birth, 13 infants died before hospital discharge, 5 transferred, and 2 withdrew from the study, leaving 117 infants with data for analysis at 36 weeks PMA. At 1-year corrected age, 80 infants born preterm (69%) returned for follow-up and an echocardiogram was performed. The median THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 197 gestational age at birth of the 80 infants born preterm was 27.0 weeks (IQR 26.0-28.0 weeks), and the median birthweight was 960 g (IQR 800-1138 g). BPD was diagnosed at 36 weeks of PMA in 48 of the 80 infants born preterm (59%) who received echocardiograms at 1-year corrected age. The median gestational age at birth of the 100 infants born at term was 39.0 weeks (IQR 38.0-40.0 weeks), and the median birthweight was 3165 g (IQR 2900-3760 g).
We compared the maternal and infant characteristics between infants born preterm with and without BPD in Table I . Among infant demographic variables, only gestational age at birth was statistically significantly different between infants born preterm with BPD and those without BPD (26 ± 1 weeks vs 27 ± 1 weeks of PMA, P < .001). None of the infants received inotropes, inhaled nitric oxide, or received other pulmonary vasodilators in the first year of age after discharge from the neonatal intensive care unit. Among the maternal variables that may affect pulmonary vascular growth and development, including chorioamnionitis, pre-eclampsia, placental abruption, and smoking, there were no significant differences between the infants born preterm with and without BPD, Table I .
All infants born preterm had significantly lower values of PAAT and PAAT:RVET than those of infants born at term (73 ± 8 milliseconds vs 98 ± 5 milliseconds and 0.31 ± 0.04 vs 0.40 ± 0.02 respectively, P < .001 for both), that persisted after adjusting for sex (b = 2.3, P = .001 and b = 2.4, P = .001, respectively) at 1-year corrected age (Figure 3 ). PAAT and PAAT:RVET significantly correlated with chronological age corrected for prematurity in both infants with BPD (r = 0.67 and 0.71) and infants without BPD (r = 0.55 and 0.62) (Figure 4 ; available at www.jpeds.com). In the infants born preterm without BPD, step-wise regression analysis of the effects of sex, birth weight, total oxygen days, total ventilator days, length of stay, common neonatal morbidities (necrotizing enterocolitis, intraventricular hemorrhage, and retinopathy of prematurity), and length of exposure to a PDA also revealed that the relation of decreased PAAT and PAAT:RVET at 1-year corrected age persisted with decreasing gestational age at birth.
Infants born preterm with BPD had decreased PAAT and PAAT:RVET at 1-year corrected age when compared with those without BPD (69 ± 5 milliseconds vs 79 ± 4 milliseconds and 0.29 ± 0.02 vs 0.33 ± 0.06 respectively, P < .01 for both), Table II . Infants born preterm without BPD had significantly lower values of PAAT and PAAT:RVET when compared with healthy infants born at term (79 ± 4 milliseconds vs 98 ± 5 milliseconds and 0.33 ± 0.06 vs 0.40 ± 0.02, both P <.001) (Figure 3) .
Postnatal steroids were administered in 26 infants (33%) at least one time during their hospital course; of these, 23 infants received postnatal steroids to treat lung disease beyond the first month of age and also were diagnosed with BPD. The 3 remaining infants received steroids in the first month of age to facilitate a trial of extubation. All infants born preterm received caffeine from birth through 34 weeks of PMA, and 15 of 80 (18%) infants who returned at 1-year corrected age received at least 1 dose of diuretics during their neonatal course; no infants were on either medication at 36 weeks of PMA. There was no statistical difference in the PAAT and PAAT:RVET between those infants who did and did not receive postnatal steroids (P = .45), and those who did and did not received diuretics (P = .34), although the study was not adequately powered to answer these questions.
A PDA was present on echocardiogram at 36 weeks of PMA in 13% (n = 6) of infants born preterm with BPD compared with 9% (n = 3) without BPD that returned at 1-year corrected age. There were no differences in PAAT or PAAT:RVET at 1-year corrected age between infants born preterm who still had PDA at 36 weeks of PMA (n = 9, 11%, adjusted for gestational age, sex, and PDA size) and those who did not have a PDA (P = .36, P = .32, respectively).
On the basis of conventional echocardiographic evidence, we found a late PH in 15% (n = 17 of 117 infants born preterm) at 36 weeks of PMA and none at 1-year corrected age. Of the 17 infants with late PH at 36 weeks, 13 met BPD criteria and 4 did not. Twelve of the 17 infants with late PH returned for follow-up at 1-year corrected age, of whom 8 (75%) were classified with BPD and 4 (25%) without BPD at 36 weeks of PMA (Figure 1 and Table III [available at www.jpeds.com]). None of these 12 infants required oxygen or respiratory support at 1-year corrected age. There were no significant differences among the maternal variables that may affect pulmonary vasculature development between the infants born preterm with and without PH ( Table I) .
Infants born preterm with late PH at 36 weeks of PMA had decreased PAAT and PAAT:RVET at 1-year corrected age when compared with infants without late PH (70 ± 4 milliseconds vs 74 ± 4 milliseconds and 0.29 ± 0.03 vs 0.32 ± 0.03 respectively, P < .01 for both), even after adjusting for the presence of BPD and presence of PDA at 36 weeks of PMA on regression analysis (b = 2.4, P = .01, b = 2.5, P < .01 and b = 2.3, P < .01, b = 2.6, P < .01, respectively). Infants born preterm without late PH also had significantly lower values of PAAT and PAAT:RVET when compared with healthy infants born at term (74 ± 4 milliseconds vs 98 ± 5 milliseconds and 0.33 ± 0.06 vs 0.40 ± 0.02, both P < .001). All 80 (100%) infants born preterm had PAAT <90 milliseconds and 51 infants born preterm (64%) had PAAT:RVET <0.31. All infants born at term had PAAT >90 milliseconds and PAAT:RVET >34.
In the preterm cohort, RV FWLS ranged from −21% to −26%, and there were strong linear correlations between PAAT and PAAT:RVET with RV FWLS (r = 0.86 and r = 0.84, respectively, P < .001) at 1-year corrected age. Because of the linear interdependence of PAAT measures with RV FWLS in the same direction, RV FWLS was not taken into account in analysis of PAAT and PAAT:RVET with BPD and PH. We have previously demonstrated in this cohort that infants with BPD and/or PH have decreased RV FWLS when compared with infants born preterm without BPD and/or PH. 4 The inverse relationships between RV FAC with PAAT and PAAT:RVET were significant but not as strong (r < 0.75 for all measures). PAAT <90 milliseconds and PAAT/RVET <0.31 detected an RV FWLS cutoff value of −24% with sensitivity of 87% and specificity of 89%, with an area under the curve of 0.88 (95% CI 0.84-0.97). The basal and mid-cavity diameters and the RV areas at end-systole and end-diastole were larger in all the infants born preterm and even more pronounced in infants with BPD and/or PH. The longitudinal diameter from the apex to the base and the proximal and distal RVOT diameters were similar in all infants born preterm and infants born at term, regardless of the presence of BPD and/or PH. We demonstrated that LV FWLS was similar between infants born at term and all infants born preterm at 1-year corrected age, irrespective of a diagnosis of BPD or late PH at 36 weeks PMA (P = .45). 4 All values for comparisons can be found in Table II .
The measurements of PAAT were feasible in 100% of infants born at term and infants born preterm using the methods previously described by our group. 15 (A DVTR was present in 11% [9/80] of infants born preterm at 1-year corrected age, Table II ). There was high degree of intraobserver agreement (bias 4.2%, 95% LOA −12.0 to +12.0; CV 5.6%) and interobserver agreement (bias 7.2%, 95% LOA −8.8 to +8.6; CV 5.0%) for PAAT measurements. PAAT:RVET had similar results.
Discussion
This prospective, longitudinal study demonstrated that infants born extremely preterm exhibit characteristics of PVD that include increased resistance, elevated pressure, and decreased compliance of the pulmonary vasculature at 1-year corrected age. The PVD, as assessed using pulmonary artery Doppler-derived PAAT and PAAT:RVET, appears to be a distinct pathology of prematurity that is present independent of clinically apparent lung disease. We found that the degree of PVD at 1-year corrected age was inversely related to the gestational age in both healthy infants born preterm and infants born preterm with established BPD and/or late PH. These findings add to the growing list of complications of being born premature that may increase susceptibility or be a marker for greater risk of late cardiovascular disease beyond the neonatal period and into early childhood, adolescence, and adulthood. 24, 25 A major barrier in detection of PVD and PH to discern their true prevalence and allow for larger scale studies of promising therapies has been the lack of accurate screening tools or universal screening guidelines for identification and stratification of patients with PH. 11, 13, 26 PVR and PAP are conventionally assessed noninvasively in infants using 2 Doppler echocardiography methods: (1) measurement of the maximal velocity of tricuspid regurgitation with the application of the modified Bernoulli equation 3, 27 ; and (2) measurement of pulmonary flow velocity indices. 21, 28 Recent studies in children and infants comparing the DVTR and right heart catheterization methods have revealed clinically relevant discrepancies between Doppler-estimated and catheter-measured PAP. 29 In a significant number of infants, the DVTR is either absent or insufficient to measure. 3, 27 PAAT is re-emerging as a quantitative method to assess pulmonary blood flow velocity characteristics in the RVOT in infants and children. 15, 16 There now exist data showing reliable correlation and agreement between PAAT and measured PAP, vascular resistance, and compliance by cardiac catheterization in children and infants that validate this noninvasive method as sensitive measure for assessing pulmonary hemodynamics. 15, 16 A shortened PAAT reflects elevated PVR and low pulmonary arterial compliance with a larger afterload to RV ejection, altering RV mechanical performance. When PAAT is modified to take into account heart rate (PAAT:RVET), the correlation is further enhanced. 15 A PAAT of <90 milliseconds and PAAT:RVET <0.31 detects infants with PVD and RV dysfunction with high a degree of sensitivity and specificity. 15 In this study, all infants born preterm had a PAAT <90 milliseconds, PAAT:RVET <0.31, and RV strain values <−26% (normal RV strain at 1 year of age is >−29%), 30 further highlighting that shorter PAAT is associated with differing degrees of RV dysfunction in patients with PVD. This implies that RV afterload is a major contributor to the observed differences in RV function. 15 In the setting of depressed RV function, elevated PVR, and decreased compliance, there is an increased time needed by the RV to develop the wall tension necessary to overcome the elevated afterload.
Impaired ventricular contraction alone might not cause an early peaking of deceleration of pulmonary systolic flow if the pulmonary vascular bed is normal 31 ; however, the combined consequences of depressed RV function, altered pulmonary hemodynamics, and decreased vascular compliance lead to a shorter PAAT. 15 PAAT also integrates the "impedance" to the forward pulsatile blood flow from backward pressure wave reflections from multiple bifurcations of the pulmonary circulation. 15 In PVD, the reduced compliant nature of the distal vascular bed causes impedance to increase and forward blood flow to decelerate early in systole as the reflected pressure wave front reaches the pulmonary trunk prematurely, causing an early systolic deceleration and early peaking of flow velocity in the pulmonary artery. 32 Thus, PAAT shortening may indicate the presence of underlying pulmonary arterial disease in children as the time to peak velocity in the pulmonary artery decreases and PAAT shortens.
Although numerous cohort and epidemiologic reports indicate that PVD is associated with the presence and degree of BPD, 5, 6, 8, 33, 34 it is important to recognize that the pulmonary vascular hemodynamics, similar to lung function, of most infants born extremely low birth weight without BPD may be abnormal, and that those infants also are at increased risk of adverse outcomes. 7, 33, 35 In this study all infants born preterm had decreased PAAT and PAAT:RVET, even in the absence of clinical lung disease, when compared with healthy infants born at term at 1 year of age. Subhedar and Shaw prospectively followed a cohort of infants born preterm to 52 weeks of corrected age and also reported lower ratios of PAAT:RVET in infants born preterm with established BPD, as compared with infants without BPD. 28 Several cross-sectional studies have described increased PAP, as measured by decreased PAAT or PAAT:RVET, in child survivors of BPD in comparison with healthy children born preterm 9, 21, 27, 36 and term. 37, 38 Benatar et al 27 and Kwon et al 9 even reported lower values of PAAT in children diagnosed with BPD and late PH during the neonatal period. In contrast, Joshi et al and Korhonen et al found that preterm survivors of BPD had no signs of elevated pulmonary pressures at 7-12 years of age, even after a trial of hypoxic exposure. 39, 40 Even if PVR and PAP "normalize" by school age in some infants born preterm, pulmonary vascular reactivity to changes in oxygen tension and inhaled nitric oxide may still persist into adolescence. 41 These studies consisted of small patient cohorts of heterogeneous prematurity and did not assess reproducibility. In comparison, our study used established and validated PAAT values of consistent reliability in relatively larger cohort of prospectively and longitudinally followed infants born at an extremely low gestational age.
The high incidence of persistent PVD 21, 28, 37 in infants born extremely preterm parallels the association of BPD with decreasing gestational age. 7 Clinical risk factors associated with persistent PVD include lower gestational age 5 and low birth weight z score. 3 In our study, multivariate analysis showed that PAAT and PAAT:RVET at 1-year corrected age were directly related to gestational age at birth in both infants born preterm with and without BPD and/or late PH. Subhedar and Shaw 28 and Fitzgerald et al 21 also reported that lower PAAT:RVET in all children born preterm corresponded to lower gestational age at birth. Although the mechanistic interrelation of both pathologies in infants born more preterm is confounded by the tandem development of pulmonary airspace and vasculature, 42 and the variability in the definitions of each disease, 3, 18, 43 some infants born preterm with severe chronic lung injury have normal pulmonary vascular pressures and right heart function, [8] [9] [10] and other infants born preterm without apparent lung disease or BPD demonstrate echocardiographic features of PVD and RV failure. [3] [4] [5] [6] Could PVD be a distinct pathology with low PAAT as a feature of prematurity, rather than a manifestation of BPD? 12, 44 Although premature birth earlier in gestation disrupts the programing of alveolar and vascular development, the response of the pulmonary circulatory system following preterm birth may subsequently induce pathologic remodeling that is characteristic of PVD with lower values of PAAT, and lead to the development of PH. 45 The confounding variables for interpretation of the PAAT and PAAT:RVET are heart rate, RV dysfunction, and the presence of large left to right shunts. 15 As the PAAT:RVET may fall with increasing heart rate, we plotted the R-R interval against the ratio and saw no statistically significant association between these variables. Consequently, we did not assess PAAT:RVET corrected for heart rate. 15 We characterized RV function with RV FLWS and FAC and saw a significant correlation between PAAT and measures of RV function, further confirming the interdependence of PAAT with RV systolic function. Because of the dependence on these variables, PAAT should be interpreted in conjunction with measures of right heart function. A large atrial septal defect (ASD) with increased left to right flow will increase volume to the right heart and falsely elevate PAAT. In this study, only 10 (13%) of the infants born extremely preterm had an ASD or patent foramen ovale, and none had an effect on PAAT, even after we adjusted for BPD, PH, and gestational age. However, this study was not powered to account for the impact of an ASD on PAAT, and the true influence of shunts is an area for further investigation. Altered LV dynamics also may contribute to abnormal pulmonary hemodynamics through its interventricular interactions with the RV and/or left heart failure that can lead to pulmonary venous congestion and PH. In this study, we demonstrated that LV FWLS, as a measure of LV systolic function, was similar between infants born at term and all infants born preterm at 1-year corrected age, irrespective of a diagnosis of BPD or late PH at 36 weeks of PMA. 4 Although peak velocity across the RVOT depends on the diameter, based on the notion that velocity is inversely proportional to the cross-sectional area, the time to peak velocity (PAAT) had no relationship with diameter across the RVOT. There were no patients with valve narrowing or stenosis in this study. 22 In conclusion, infants born preterm exhibit PVD characteristics at 1-year corrected age, regardless of neonatal lung disease status, suggesting the existence of PVD beyond infancy. Although this PVD is commonly associated with BPD, it also appears to be a distinct pathology of prematurity. PAAT measurements may offer a reliable, noninvasive tool for screening and longitudinal monitoring of pulmonary hemodynamics in infants. C offey describes a study of 10 children with acute otitis media (AOM) treated with intramuscular ampicillin, which was aimed to determine whether the drug distributed to the middle ear sufficiently to eradicate common bacterial pathogens. Analysis of middle ear exudates obtained by tympanocentesis 65-80 minutes after injection confirmed that the concentration of ampicillin was well above the minimal inhibitory concentration of contemporary isolates of Haemophilus influenzae and streptococcus. The study itself has little relevance to pediatric practice today. The drug and mode of delivery are not currently employed in the outpatient management of AOM; consideration of Moraxella catarrhalis, only later recognized as a cause of AOM, is not included; and the study predated the widespread dissemination of antimicrobial resistance in community-acquired middle ear pathogens. Nevertheless, the report did presage the use of tympanocentesis in studying therapeutics in AOM, which has figured prominently in trials testing the efficacy of new antibiotics. While in many new-drug trials, the study entry and outcome were based exclusively on clinical criteria ("clinical design"), in other trials, the diagnosis at entry was confirmed microbiologically through tympanocentesis ("single-tap design"). In still others, a second tympanocentesis was employed to document microbiological in addition to clinical cure ("double-tap design"). Inclusion of taps in comparative drug trials of patients with AOM did have some down-sides. Single-tap studies assured an accurately defined population, but tympanocentesis, effectively a drainage procedure, may have influenced outcome. Double-tap studies required a second invasive procedure in many children who had clinically improved. In addition, if the timing of the second tympanocentesis was early after study entry, bacterial growth sometimes was detected but did not predict ultimate clinical and microbiological cure.
Tympanocentesis has provided information regarding AOM therapeutics additional to, and perhaps more important than, that pertaining to comparative drug efficacy. The microbiology of the condition is constantly shifting due to changes in the epidemiology of circulating pneumococcal serotypes driven by universal vaccination and to the variations in antimicrobial resistance in Streptococcus pneumoniae and nontypeable H influenzae. Besides providing a window into this evolving epidemiology, tympanocentesis studies also have generated valuable antibiotic pharmacokinetic data, as in the Coffey study. This information, coupled with pharmacodynamic considerations, allows prediction of relative drug efficacy that can accommodate the inevitable fluxes in AOM microbiology. June 2018
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